Literature DB >> 28657909

Life-Threatening and Suspicious Lesions Caused by Mechanical Cardiopulmonary Resuscitation.

Louise Milling1, Peter Mygind Leth, Birgitte Schmidt Astrup.   

Abstract

Chest compression devices for mechanical cardiopulmonary resuscitation (CPR) have become more common. Here, we report the case of a young woman who attempted resuscitated with LUCAS™2 after she was found unconscious at home. At autopsy, we found extensive intramuscular hemorrhages in posterior neck, between the scapulae, and in the lumbar region. Investigation of internal organs showed injuries to the lung, spleen, and kidney. The extension of the injuries gave rise to suspicion of homicide by smothering, which police investigation subsequently did not support. The pattern of injury could be attributed to automatic compression decompression CPR with LUCAS™2.The injuries may have been lethal had the patient survived. For the forensic pathologists, it is important to remain updated on developments in treatment techniques to avoid pitfalls when interpreting injury.Larger studies, prospective or retrospective, may be able to qualify the possible risks of automatic compression decompression CPR even further.

Entities:  

Mesh:

Year:  2017        PMID: 28657909     DOI: 10.1097/PAF.0000000000000321

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  2 in total

1.  Chest compression-associated injuries in cardiac arrest patients treated with manual chest compressions versus automated chest compression devices (LUCAS II) - a forensic autopsy-based comparison.

Authors:  Benjamin Ondruschka; Christina Baier; Ronny Bayer; Niels Hammer; Jan Dreßler; Michael Bernhard
Journal:  Forensic Sci Med Pathol       Date:  2018-09-10       Impact factor: 2.007

2.  Preference for Aggressive End-of-Life Care among Advanced Cancer Patients in Wuhan, China: A Cross-Sectional Study.

Authors:  Jing Liao; Bei Wu; Jing Mao; Ping Ni
Journal:  Int J Environ Res Public Health       Date:  2020-09-10       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.